Serostatus of Epstein–Barr Virus in Iranian Ms Patients

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Serostatus of Epstein–Barr Virus in Iranian Ms Patients Publisher Pubmed

Karampoor S¹ ; Zahednasab H² ; Pirkouh AA³ ; Monavari SHR³ ; Ramagopalan S⁴ ; Keyvani H³

Source: Acta Neurologica Belgica Published:2016

Abstract

Multiple sclerosis (MS) is a common, complex disorder. Associations of MS with Epstein–Barr virus (EBV) infection in Caucasian populations are well documented. However, in the Iranian population, previous studies have been conflicting. Sixty patients with MS and 50 healthy controls were tested for anti-EBV antibodies using chemiluminescent assays. All MS patients to be seropositive for EBV as compared to 82 % of controls (p = 0.0006). A strong, significant association of MS with EBV infection was documented, similar to studies in first world populations. Future studies should investigate the temporal sequence of infection to try to understand the cause of the recent increase in MS risk in Iran. © 2015, Belgian Neurological Society.

Related Docs

View other Related Docs

1. Differential Serostatus of Epstein-Barr Virus in Iranian Ms Patients With Various Clinical Patterns, Medical Journal of the Islamic Republic of Iran (2018)

2. Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review, Neuroepidemiology (2016)

3. Ebv Infection and Vitamin D in Multiple Sclerosis Patients, Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis (2017)

Experts (# of related papers)

View all Related Experts

Mohammad Ali Sahraian (10)

Sharareh Eskandarieh (5)

Other Related Docs

4. The Epidemiologic Trend of Multiple Sclerosis in Razavi Khorasan Province, Iran in Fifteen-Year Period, Multiple Sclerosis and Related Disorders (2025)

5. Molecular Detection of Epstein–Barr Virus, Human Herpes Virus 6, Cytomegalovirus, and Hepatitis B Virus in Patients With Multiple Sclerosis, Middle East Journal of Digestive Diseases (2020)

6. Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis, Neuroepidemiology (2015)

7. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)

8. Covid-19 and Its Implications on the Clinico-Radiological Course of Multiple Sclerosis: A Case–Control Study; [Covid-19 Y Sus Implicaciones En El Curso Clinico-Radiologico De La Esclerosis Multiple: Un Estudio De Casos Y Controles], Medicina Clinica (2023)

9. Prevalence of Cytomegalovirus in Patients With Multiple Sclerosis: A Case-Control Study in Northern Iran, Jundishapur Journal of Microbiology (2016)

10. Infectious Agents and Different Course of Multiple Sclerosis: A Systematic Review, Acta Neurologica Belgica (2018)

11. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran, Iranian Journal of Public Health (2017)

12. Prevalence and Incidence of Multiple Sclerosis in Ardabil, Northwest of Iran, Multiple Sclerosis and Related Disorders (2021)

13. Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis: The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (Menactrims), Current Medical Research and Opinion (2015)

14. Insights Into the Interplay Between Epstein-Barr Virus (Ebv) and Multiple Sclerosis (Ms): A State-Of-The-Art Review and Implications for Vaccine Development, Health Science Reports (2024)

15. Consensus Recommendations for Diagnosis and Treatment of Multiple Sclerosis: 2023 Revision of the Menactrims Guidelines, Multiple Sclerosis and Related Disorders (2024)

17. Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis: 2019 Revisions to the Menactrims Guidelines, Multiple Sclerosis and Related Disorders (2020)

18. Increasing Prevalence of Familial Recurrence of Multiple Sclerosis in Iran: A Population Based Study of Tehran Registry 1999-2015, BMC Neurology (2018)

19. Follow-Up of Patients With Multiple Sclerosis After Covid-19 Vaccination With Sinopharm Vaccine, Caspian Journal of Neurological Sciences (2023)

20. Prevalence and Predictors of Dysphagia in Iranian Patients With Multiple Sclerosis, Medical Journal of the Islamic Republic of Iran (2017)

Style	Citing Format
MLA	Karampoor S, et al.. "Serostatus of Epstein–Barr Virus in Iranian Ms Patients." Acta Neurologica Belgica, vol. 116, no. 1, 2016, pp. 43-46.
APA	Karampoor S, Zahednasab H, Pirkouh AA, Monavari SHR, Ramagopalan S, Keyvani H (2016). Serostatus of Epstein–Barr Virus in Iranian Ms Patients. Acta Neurologica Belgica, 116(1), 43-46.
Chicago	Karampoor S, Zahednasab H, Pirkouh AA, Monavari SHR, Ramagopalan S, Keyvani H. "Serostatus of Epstein–Barr Virus in Iranian Ms Patients." Acta Neurologica Belgica 116, no. 1 (2016): 43-46.
Harvard	Karampoor S et al. (2016) 'Serostatus of Epstein–Barr Virus in Iranian Ms Patients', Acta Neurologica Belgica, 116(1), pp. 43-46.
Vancouver	Karampoor S, Zahednasab H, Pirkouh AA, Monavari SHR, Ramagopalan S, Keyvani H. Serostatus of Epstein–Barr Virus in Iranian Ms Patients. Acta Neurologica Belgica. 2016;116(1):43-46.
BibTex	@article{ author = {Karampoor S and Zahednasab H and Pirkouh AA and Monavari SHR and Ramagopalan S and Keyvani H}, title = {Serostatus of Epstein–Barr Virus in Iranian Ms Patients}, journal = {Acta Neurologica Belgica}, volume = {116}, number = {1}, pages = {43-46}, year = {2016} }
RIS	TY - JOUR AU - Karampoor S AU - Zahednasab H AU - Pirkouh AA AU - Monavari SHR AU - Ramagopalan S AU - Keyvani H TI - Serostatus of Epstein–Barr Virus in Iranian Ms Patients JO - Acta Neurologica Belgica VL - 116 IS - 1 SP - 43 EP - 46 PY - 2016 ER -

Science Communicator Platform

Authors

Abstract